The Institute of Cancer Research London

Therapeutic Approaches: Small Molecules

Therapeutic Areas of Expertise: Oncology

Center/Program Highlights:

The Cancer Research UK Cancer Therapeutics Unit is a comprehensive small molecule drug discovery center specializing in oncology. Since 2005 we have discovered 16 drug candidates, 6 of these have entered the clinic and our drug abiraterone was approved for late stage prostate cancer. Other drug candidate in the clinic include inhibitors of HSP90, Pi3 kinase and AKT/PKB.

Sources of Funding: Philanthropy, Industry Partnerships, Disease Foundations, University, Revenue, Federal/State,


Institutional Affiliation(s): Cancer Research UK

The Institute of Cancer Research
15 Cotswold Road
Surrey, SM2 5NG
United Kingdom

Center/Program Start Date: 1997

Number of Employees: 163